Glycobiology Market is expanding rapidly with growing adoption of AI solutions by healthcare organizations

Glycobiology is the study of the structure, function, and biology of carbohydrates, also called glycans. It is the general classification for carbohydrates covalently linked with other chemical species such as saccharides, lipids, peptides, and proteins. Polysaccharides and glycans play an important structural role in connective tissues. Glycobiology or glycomics find a wide variety of application in areas such as industrial applications, therapeutic application, diagnostic applications, and drug discovery and development.

Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/3639

According to the International Agency for Research on Cancer (IARC), worldwide, one in five people develop cancer during their lifetime, and one in eight men and one in eleven women die from the disease. Moreover, according to National Cancer Institute, in 2020, around 1,806,590 new cases of cancer were expected to be diagnosed in the United States and around 606,520 people were expected to die from the disease.

For instance, in 2020, researchers from Universidade do Porto, Portugal, reported assessment of the role of O-glycan using glycoengineered gastric cancer models in the detection of CD44v9 by monoclonal antibodies. O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer. Furthermore, increasing prevalence of HIV/AIDS is also expected to propel the glycobiology market growth.

Rising investments from both government and non-government organizations have enabled researchers to develop new glycobiology or glycomics tools, as there is a need for advanced analytical tools/methods to study pathogen and human glycobiology in disease and health. Hereafter, there has been an increase in proteomics and biomedical research, leading to the growth of the glycobiology market. For instance, in 2020, researchers from the University of Minho developed a neurocompatible strategy to image temporal distribution of glycoproteins during neuronal development using Cu-free click chemistry. This in turn is also expected to aid the glycobiology market growth.

Major Market Competitors: Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, Agilent Technologies, Inc.

Download PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/3639

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

𝗔𝗯𝗼𝘂𝘁 𝗖𝗼𝗵𝗲𝗿𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:-
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.

This release was published on openPR.